Patient monitoring

How to meet the 10 top challenges in Phase 1 clinical trials

In this post, I’ll share our experiences at flaskdata.io with early stage drug and device vendors doing their first Phase 1 safety study.  You’ll see a common thread of speed and data quality. I’ll tear down the challenges for early stage life science companies into 10 parts. Early stage drug and device clinical trials are …

How to meet the 10 top challenges in Phase 1 clinical trials Read More »

High-performance clinical teams speak softly

The advantages of speaking softly I started thinking about the constraints on eClinical technology for decentralized clinical trials and patient-centric product development. The best planned patient-centric trial will not succeed if the data quality is poor at the sites. When a CRA on the team is disgruntled, it is infectious. Speed and efficiency in your …

High-performance clinical teams speak softly Read More »

How to ensure patient adherence in decentralized clinical trials

With COVID-19, it is challenging to physically visit patients in clinical trials. Life science companies are increasingly  turning to decentralized clinical trial models. With 10X more data from patients and their connected devices, how can we assure patient adherence to the clinical protocol Are we discovering new opportunities or forgetting old lessons learned? In this …

How to ensure patient adherence in decentralized clinical trials Read More »

How to get digital health apps to work together – the power of simplicity

Sunrise off the coast of the Dead Sea in Israel We are using too many buzzwords to defeat SARS-COV-2 I thought about buzz-words last night. My wife is now a compulsive news watcher. Personally — TV news and papers bother me from getting productive work done at our clinical data startup flaskdata.io — accelerating clinical trials for …

How to get digital health apps to work together – the power of simplicity Read More »

Hack back the user interface for clinical trials

As part of my campaign for site-coordinator and study-monitor centric clinical trials; we first need to understand how to exploit a vulnerability in human psychology. As a security analyst, this is the way I look at things – exploits of vulnerabilities. In 2007, B.J. Fogg, founder and director of the Stanford Behavior Design Lab taught a …

Hack back the user interface for clinical trials Read More »

Scroll to Top